689 related articles for article (PubMed ID: 11472319)
1. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
[TBL] [Abstract][Full Text] [Related]
2. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
[TBL] [Abstract][Full Text] [Related]
3. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
[TBL] [Abstract][Full Text] [Related]
4. Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.
Mukaisho K; Hagiwara T; Nakayama T; Hattori T; Sugihara H
World J Gastroenterol; 2014 Sep; 20(34):11962-5. PubMed ID: 25232231
[TBL] [Abstract][Full Text] [Related]
5. Does acid suppression by antacids and H2 receptor antagonists increase the incidence of atrophic gastritis in patients with or without H. pylori gastritis?
Carter M; Katz DL; Haque S; DeLuca VA
J Clin Gastroenterol; 1999 Sep; 29(2):183-7. PubMed ID: 10478882
[TBL] [Abstract][Full Text] [Related]
6. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
7. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.
Kuipers EJ; Nelis GF; Klinkenberg-Knol EC; Snel P; Goldfain D; Kolkman JJ; Festen HP; Dent J; Zeitoun P; Havu N; Lamm M; Walan A
Gut; 2004 Jan; 53(1):12-20. PubMed ID: 14684569
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
[TBL] [Abstract][Full Text] [Related]
9. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
Uemura N; Okamoto S; Yamamoto S; Matsumura N; Yamaguchi S; Mashiba H; Sasaki N; Taniyama K
Aliment Pharmacol Ther; 2000 Oct; 14(10):1345-52. PubMed ID: 11012481
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
Kuipers EJ; Klinkenberg-Knol EC; Meuwissen SG
Yale J Biol Med; 1999; 72(2-3):211-8. PubMed ID: 10780583
[TBL] [Abstract][Full Text] [Related]
11. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia?
Rugge M; Di Mario F; Cassaro M; Baffa R; Farinati F; Rubio J; Ninfo V
Histopathology; 1993 Jan; 22(1):9-15. PubMed ID: 8436350
[TBL] [Abstract][Full Text] [Related]
12. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection.
Annibale B; Negrini R; Caruana P; Lahner E; Grossi C; Bordi C; Delle Fave G
Helicobacter; 2001 Sep; 6(3):225-33. PubMed ID: 11683925
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
[TBL] [Abstract][Full Text] [Related]
16. Review article: is Helicobacter pylori status relevant in the management of GORD?
Vigneri S; Termini R; Savarino V; Pace F
Aliment Pharmacol Ther; 2000 Oct; 14 Suppl 3():31-42. PubMed ID: 11050485
[TBL] [Abstract][Full Text] [Related]
17. Atrophic corpus gastritis and Helicobacter pylori infection in primary biliary cirrhosis.
Dohmen K; Shigematsu H; Miyamoto Y; Yamasaki F; Irie K; Ishibashi H
Dig Dis Sci; 2002 Jan; 47(1):162-9. PubMed ID: 11837719
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():71-88. PubMed ID: 9146793
[TBL] [Abstract][Full Text] [Related]
19. The relationships between chronic gastritis and gastric acid secretion.
Sipponen P; Kekki M; Seppälä K; Siurala M
Aliment Pharmacol Ther; 1996 Apr; 10 Suppl 1():103-18. PubMed ID: 8730265
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammation at the gastroesophageal junction (carditis) appears to be a specific finding related to Helicobacter pylori infection and gastroesophageal reflux disease. The Central Finland Endoscopy Study Group.
Voutilainen M; Färkkilä M; Mecklin JP; Juhola M; Sipponen P
Am J Gastroenterol; 1999 Nov; 94(11):3175-80. PubMed ID: 10566710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
